Qingdao Baheal Medical INC. (SHE:301015)
China flag China · Delayed Price · Currency is CNY
25.86
-0.34 (-1.30%)
Aug 21, 2026, 3:04 PM CST

SHE:301015 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Cash & Equivalents
2,3772,1371,4671,3441,0481,276
Trading Asset Securities
366.3264.4644.9927.6227.2240.77
Cash & Short-Term Investments
2,7432,4021,5121,3721,0751,317
Cash Growth
47.00%58.81%10.23%27.63%-18.38%15.32%
Accounts Receivable
1,6811,9602,2162,4642,2321,943
Other Receivables
54.8376.44161.58214.7844.4341.34
Receivables
1,7352,0362,3772,6792,2771,984
Inventory
1,085895.57927.75861.67650.1623.85
Prepaid Expenses
----0.60.55
Other Current Assets
551.39383.94293.35205.94255.48165.91
Total Current Assets
6,1145,7185,1115,1184,2584,092
Property, Plant & Equipment
895.84885.47810.65672.15432.99225.75
Long-Term Investments
965.87901.78742.62263.95181.57151.71
Goodwill
112.49112.49112.49107.60.695.96
Other Intangible Assets
267.47227.52227.59140.0956.7728.65
Long-Term Deferred Tax Assets
84.7486.7858.176.5736.6532.85
Long-Term Deferred Charges
74.3676.740.7334.318.018.3
Other Long-Term Assets
52.67103.89.434.555.6158.02
Total Assets
8,5688,1127,1136,4175,0304,603

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Accounts Payable
1,0661,2191,1631,072990.3845.76
Accrued Expenses
68.81308.27229.97206.1211.14138.26
Short-Term Debt
2,3771,9321,099513.021,1651,189
Current Portion of Long-Term Debt
78.1350.6943.4161.44--
Current Portion of Leases
-34.2627.8720.7827.3415.42
Current Income Taxes Payable
83.1154.6464.78101.4733.9932.52
Current Unearned Revenue
179.25146.65118.5297.892.48113.78
Other Current Liabilities
425.75232.03512.32319.0683.5466.32
Total Current Liabilities
4,2783,9773,2582,3922,6042,401
Long-Term Debt
1,2531,2531,113771.93--
Long-Term Leases
105.01109.6102.5687.41145.3422.21
Long-Term Unearned Revenue
12.4512.9111.4313.6--
Long-Term Deferred Tax Liabilities
20.1917.3418.3933.541.135.85
Other Long-Term Liabilities
--5---
Total Liabilities
5,6695,3704,5083,2982,7502,429

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Common Stock
525.62525.62525.62525.61525.1525.1
Additional Paid-In Capital
17.9616.31-653.47411.61418.31
Retained Earnings
1,9481,8251,7501,6101,3641,212
Comprehensive Income & Other
96.7596.6798.91101.631.652.11
Total Common Equity
2,5892,4632,3752,8912,3022,157
Minority Interest
309.82278.7229.76228.4-22.1116.76
Shareholders' Equity
2,8992,7422,6053,1192,2802,174
Total Liabilities & Equity
8,5688,1127,1136,4175,0304,603

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Total Debt
3,8143,3802,3851,4551,3381,226
Net Cash (Debt)
-1,071-978.05-872.59-82.51-262.7190.77
Net Cash Growth
------
Net Cash Per Share
-2.00-1.83-1.61-0.15-0.500.18
Filing Date Shares Outstanding
525.62525.62525.62519.55525.1525.1
Total Common Shares Outstanding
525.62525.62525.62519.55525.1525.1
Working Capital
1,8361,7401,8532,7271,6541,691
Book Value Per Share
4.934.694.525.564.384.11
Tangible Book Value
2,2092,1232,0352,6432,2452,123
Tangible Book Value Per Share
4.204.043.875.094.274.04
Buildings
-608.41504.28464.74206.13206.13
Machinery
-544.22450.97338.9691.278.02
Construction In Progress
-67.69152.26143.2980.58.78